✦ LIBER ✦

Cancer immunotherapy moves towards phase II testing

✍ Scribed by Gill Higgins

Book ID: 120877439
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 1997
Weight: 735 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-199710790-00003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Active immunotherapy for non-small-cell

Active immunotherapy for non-small-cell lung cancer: moving toward a reality

✍ Perez, Cesar A ;Santos, Edgardo S ;Raez, Luis E 📂 Article 📅 2011 🏛 Expert Reviews 🌐 English ⚖ 343 KB

Autologous cytokine-induced killer cell

Autologous cytokine-induced killer cell immunotherapy in lung cancer: a phase II clinical study

✍ Runmei Li, Changli Wang, Liang Liu, Chunjuan Du, Shui Cao, Jinpu Yu, Shizhen Emi 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 288 KB

Maintenance immunotherapy in recurrent o

Maintenance immunotherapy in recurrent ovarian cancer: Long term follow-up of a phase II study

✍ Francesco Recchia; Ferdinando Di Orio; Giampiero Candeloro; Gabriele Guerriero; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 231 KB

Improved two-stage tests for stratified

Improved two-stage tests for stratified phase II cancer clinical trials

✍ Myron N. Chang; Jonathan J. Shuster; Wei Hou 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

Autologous Dendritic Cell Based Adoptive

Autologous Dendritic Cell Based Adoptive Immunotherapy of Patients with Colorectal Cancer—A Phase I-II Study

✍ Hunyadi, JÃ¡nos; AndrÃ¡s, Csilla; SzabÃ³, Imre; SzÃ¡ntÃ³, JÃ¡nos; Szluha, KornÃ© 📂 Article 📅 2013 🏛 Springer Netherlands 🌐 English ⚖ 286 KB

Adjuvant MAGE-A3 Immunotherapy in Resect

Adjuvant MAGE-A3 Immunotherapy in Resected Non-Small-Cell Lung Cancer: Phase II Randomized Study Results

✍ Vansteenkiste, J.; Zielinski, M.; Linder, A.; Dahabreh, J.; Gonzalez, E. E.; Mal 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 294 KB